Tip of the iceberg: here's an article about how a
Post# of 72440
http://dealbook.nytimes.com/2014/01/17/key-wi...h_20140118
Anyone think this is the only case like this?
We have SO often seen frontrunning of smaller biotechs, and then news comes out. So a trader friend of mine who disregards anything but direction and volume may have the right idea.